Cleared Traditional

SPECTACLE FRAME OR EYEGLASS FRAMES (K945176) - FDA 510(k) Clearance

Class I Ophthalmic device.

K945176 · Optipia Trading Co. · Ophthalmic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1994
Decision
52d
Days
Class 1
Risk

K945176 is an FDA 510(k) clearance for the SPECTACLE FRAME OR EYEGLASS FRAMES. Classified as Frame, Spectacle (product code HQZ), Class I - General Controls.

Submitted by Optipia Trading Co. (Daegu, KR). The FDA issued a Cleared decision on December 15, 1994 after a review of 52 days - a notably fast clearance cycle.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.5842 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Optipia Trading Co. devices

Submission Details

510(k) Number K945176 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 24, 1994
Decision Date December 15, 1994
Days to Decision 52 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
58d faster than avg
Panel avg: 110d · This submission: 52d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code HQZ Frame, Spectacle
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 886.5842
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.